# PetVivo Holdings, Inc.: filings

PETV · OTC · CIK 1512922 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/petv.md) · [Financials](/companies/petv/financials.md) · [Filings](/companies/petv/filings.md) · [Insiders](/companies/petv/insiders.md)

## Reports and events: 288 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 231, 8-K 167, 10-Q 45, 3 26, SC 13G 18, NT 10-Q 16, 10-K 15, 10-Q/A 15, UPLOAD 15, CORRESP 12, 4/A 11, 8-K/A 10, SC 13G/A 10, SC 13D 9, 10-K/A 8, NT 10-K 8, SCHEDULE 13G/A 8, 424B5 7, DEF 14C 7, PRE 14C 7, PRER14C 7, S-1/A 6, SC 13D/A 5, 5 4, EFFECT 4, 424B3 3, DEF 14A 3, DEFA14A 3, S-1 2, S-8 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, 25-NSE 1, 424B4 1, 8-A12B 1, 8-A12G 1, CERT 1, D 1, POS AM 1, S-3 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-22 | 11:00 ET | [8-K](/filings/0001493152-26-043639.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-043639 |
| 2026-09-22 | 11:00 ET | [8-K](/filings/0001493152-26-043641.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-043641 |
| 2026-09-15 | 20:04 ET | [SCHEDULE 13D/A](/filings/0001099910-26-000264.md) | Ownership report, active investor, amended | 0001099910-26-000264 |
| 2026-08-20 | 13:20 ET | [8-K](/filings/0001493152-26-039397.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-039397 |
| 2026-08-14 | 20:58 ET | [10-Q](/filings/0001493152-26-038477.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038477 |
| 2026-07-29 | 22:10 ET | [8-K](/filings/0001493152-26-035053.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035053 |
| 2026-07-27 | 18:28 ET | [8-K](/filings/0001493152-26-034762.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-034762 |
| 2026-06-29 | 21:30 ET | [10-K](/filings/0001493152-26-031136.md) | Annual report, period 2026-03-31 | 0001493152-26-031136 |
| 2026-06-25 | 21:23 ET | [8-K](/filings/0001493152-26-030193.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030193 |
| 2026-06-11 | 22:04 ET | [8-K](/filings/0001493152-26-028172.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-028172 |
| 2026-04-17 | 20:03 ET | [8-K](/filings/0001493152-26-017819.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-017819 |
| 2026-03-27 | 22:06 ET | [8-K/A](/filings/0001493152-26-013009.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-013009 |
| 2026-03-16 | 21:30 ET | [8-K](/filings/0001493152-26-010335.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-010335 |
| 2026-03-13 | 21:09 ET | [SCHEDULE 13D/A](/filings/0001099910-26-000119.md) | Ownership report, active investor, amended | 0001099910-26-000119 |
| 2026-03-04 | 01:14 ET | [8-K](/filings/0001493152-26-008745.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008745 |
| 2026-02-17 | 21:32 ET | [10-Q](/filings/0001493152-26-007150.md) | Quarterly report, period 2025-12-31 | 0001493152-26-007150 |
| 2026-01-29 | 21:11 ET | [8-K](/filings/0001493152-26-004231.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-004231 |
| 2026-01-22 | 18:06 ET | [8-K](/filings/0001493152-26-003220.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-003220 |
| 2026-01-16 | 21:30 ET | [SCHEDULE 13D](/filings/0001099910-26-000031.md) | Ownership report, active investor | 0001099910-26-000031 |
| 2026-01-14 | 18:01 ET | [8-K](/filings/0001493152-26-002223.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-002223 |
| 2025-11-14 | 21:00 ET | [10-Q](/filings/0001493152-25-023398.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023398 |
| 2025-11-03 | 19:18 ET | [8-K](/filings/0001493152-25-020574.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020574 |
| 2025-10-30 | 19:24 ET | [8-K](/filings/0001493152-25-020203.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-020203 |
| 2025-09-30 | 10:03 ET | [8-K](/filings/0001493152-25-016139.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-016139 |
| 2025-08-14 | 20:01 ET | [10-Q](/filings/0001493152-25-011967.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011967 |
| 2025-07-10 | 21:06 ET | [10-K](/filings/0001641172-25-018617.md) | Annual report, period 2025-03-31 | 0001641172-25-018617 |
| 2025-06-24 | 17:44 ET | [8-K](/filings/0001641172-25-016271.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-016271 |
| 2025-06-20 | 10:23 ET | [8-K](/filings/0001641172-25-015708.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-015708 |
| 2025-06-16 | 19:36 ET | [8-K](/filings/0001641172-25-015235.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-015235 |
| 2025-06-12 | 23:08 ET | [8-K](/filings/0001641172-25-014760.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001641172-25-014760 |
| 2025-05-07 | 15:48 ET | [8-K](/filings/0001641172-25-008992.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-008992 |
| 2025-04-08 | 19:35 ET | [8-K](/filings/0001641172-25-003208.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-003208 |
| 2025-03-31 | 18:45 ET | [8-K/A](/filings/0001641172-25-001616.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-001616 |
| 2025-03-31 | 10:15 ET | [8-K](/filings/0001641172-25-001429.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-001429 |
| 2025-03-26 | 00:28 ET | [8-K](/filings/0001641172-25-000658.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-000658 |
| 2025-03-10 | 17:38 ET | [8-K](/filings/0001493152-25-009657.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-009657 |
| 2025-02-28 | 14:53 ET | [8-K](/filings/0001493152-25-008632.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008632 |
| 2025-02-18 | 14:38 ET | [8-K](/filings/0001493152-25-007121.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-007121 |
| 2025-02-18 | 14:33 ET | [8-K](/filings/0001493152-25-007118.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-007118 |
| 2025-02-14 | 19:45 ET | [10-Q](/filings/0001493152-25-006783.md) | Quarterly report, period 2024-12-31 | 0001493152-25-006783 |
| 2025-02-13 | 19:46 ET | [8-K](/filings/0001493152-25-006395.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-006395 |
| 2025-02-04 | 16:10 ET | [8-K](/filings/0001493152-25-004803.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-004803 |
| 2025-01-02 | 21:56 ET | [8-K](/filings/0001493152-25-000086.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-000086 |
| 2024-12-26 | 22:01 ET | [8-K](/filings/0001493152-24-052142.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-052142 |
| 2024-11-14 | 21:00 ET | [10-Q](/filings/0001493152-24-045778.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045778 |
| 2024-10-10 | 18:34 ET | [8-K](/filings/0001493152-24-040705.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-040705 |
| 2024-10-01 | 15:16 ET | [8-K](/filings/0001493152-24-038960.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-038960 |
| 2024-09-26 | 13:11 ET | [8-K](/filings/0001493152-24-038223.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-038223 |
| 2024-09-06 | 21:00 ET | [8-K](/filings/0001493152-24-035333.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-035333 |
| 2024-08-14 | 20:00 ET | [10-Q](/filings/0001493152-24-032139.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032139 |

Page 1 of 6. [Older](/companies/petv/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.